Pharmaceuticals

Advances of Qilu Pharmaceutical’s QL1706 in Clinical Research Presented at ASCO Annual Meeting

by

JINAN, China, May 31, 2023 /PRNewswire/ — The American Society of Clinical Oncology (ASCO) recently announced the selected abstracts for the prestigious ASCO 2023 Annual Meeting. Four clinical research abstracts on QL1706 (iparomlimab/tuvonralimab), an innovative bifunctional antibody for immunotherapy, were accepted in the Poster Session. Two of the posters focus on the latest clinical research progress of Qilu … Read more

Hoag Hospital clinical study demonstrates Luna reduces post-surgical rehab costs by 52%

by

ROCKLIN, Calif., May 31, 2023 /PRNewswire/ — In a groundbreaking study, Hoag Hospital, a leading not-for-profit regional health care delivery network in Orange County, California, presented the results of a two-year analysis at the 2023 American Association of Orthopedic Executives (AAOE) conference. The study demonstrated that the Luna in-home outpatient physical therapy care model reduces costs … Read more

Cambrex Celebrates Grand Opening of New Q1 Scientific Facility in Belgium and Secures First Stability Storage Commercial Agreement

by

EAST RUTHERFORD, N.J, May 31, 2023 /PRNewswire/ — Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, yesterday celebrated the grand opening of its new Q1 Scientific facility in Belgium and announced the signing of a new commercial agreement with QUALIblood, … Read more

Sun Pharma and Philogen enter into an Exclusive Distribution, License, and Supply Agreement for Commercializing specialty product, NIDLEGY™ in Europe, Australia and New Zealand USA – English USA – English

by

MUMBAI, India and SIENA, Italy, May 30, 2023 /PRNewswire/ — Sun Pharmaceutical Industries Limited (Reuters: SUN.BO), (Bloomberg: SUNP IN), (NSE: SUNPHARMA), (BSE: 524715) (together with its subsidiaries and/or associated companies, “Sun Pharma”) and Philogen S.p.A (BIT: PHIL) today announced that they have entered into a licensing agreement for commercializing Philogen’s specialty product, Nidlegy™ (Daromun) in … Read more

Metformin Hydrochloride Market to Surpass USD 602.81 Million By 2031| Growth Market Reports

by

PUNE, India, May 30, 2023 /PRNewswire/ — According to a recent market study published by Growth Market Reports, titled, “Metformin Hydrochloride Market Segments – By Type (Metformin Hydrochloride-Immediate Release, Metformin Hydrochloride-Extended Release), By Distribution Channel (Hospital Pharmacy, Drug Store, Retail Pharmacy, Online Pharmacy), and Region: Size, Share, Trends and Opportunity Analysis, 2023-2031“, the market size was USD … Read more

Se otorga la cuarta aprobación IDE de Concept Medical para el balón recubierto de sirolimus MagicTouch para el tratamiento de la enfermedad de la arteria femoral superficial (SFA) USA – español USA – English USA – English USA – Deutsch

by

TAMPA, Fla., 30 de mayo de 2023 /PRNewswire/ — El 24 de mayo de 2023, la FDA de EE.UU. otorgó una exención de dispositivo de investigación (IDE) para el balón recubierto de sirolimus (SCB) MagicTouch PTA de Concept Medical Inc para el tratamiento de las arterias femorales superficiales (SFA). Esto marca la cuarta aprobación de IDE para el balón … Read more

Pain Relief Therapeutics Market to Grow Significantly by 2029- Brandessence Market Research

by

LONDON, May 29, 2023 /PRNewswire/ — Pains or aches can be a resultant of injuries, diseases, muscle or bone related issues, among others. Frequent aches disrupt our quality of life and prevents us from doing several things. Pain relief therapeutics have played a significant role in improving the quality of life for countless individuals worldwide. … Read more

Concept Medical’s fourth IDE approval for the MagicTouch Sirolimus Coated Balloon is granted for the treatment of Superficial Femoral Artery Disease (SFA)

by

TAMPA, Fla., May 29, 2023 /PRNewswire/ — The US FDA, on the 24th of May 2023, granted an Investigational Device Exemption (IDE) approval for Concept Medical Inc’s Sirolimus Coated Balloon (SCB) MagicTouch  PTA for the treatment of Superficial Femoral Arteries (SFA). This marks the fourth IDE approval for the Company’s Sirolimus coated balloon. The Company has … Read more

Harbour BioMed Reports Results of Phase Ib Clinical Trial of Porustobart in Combination of Toripalimab in Patients with Hepatocellular Carcinoma at ASCO 2023

by

Porustobart in combination of toripalimab showed promising anti-tumor activity Porustobart in combination of toripalimab showed acceptable safety profile in HCC Porustobart in combination of toripalimab showed favorable PK/PD signature CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, May 28, 2023 /PRNewswire/ — Harbour BioMed (the “Company”, HKEX: 02142), a global biopharmaceutical company committed to the discovery, … Read more

Menarini Group compartilha nova análise do estudo clínico EMERALD do ORSERDU® (Elacestrant) em câncer de mama metastático na ASCO 2023

by

ORSERDU (elacestrant) foi aprovado em janeiro de 2023 pelo FDA para câncer de mama avançado ou metastático positivo para receptor de estrogênio (ER), receptor 2 do fator de crescimento epidérmico humano (HER2) negativo com mutações ESR1 (ESR1-mut), que são encontradas em até 40% dos tumores  Em pacientes cujos tumores abrigam ESR1-mut, uma análise post-hoc anterior … Read more